#DiabetesCare #PrecisionMedicine #MetabolicHealth #LowerTheDose #HealthcareInnovation To view or add a comment, sign in In our recent publication in Diabetes, Obesity and Metabolism, together with Professors Kokkinos and le Roux, we articulate a perspective grounded in robust scientific evidence, yet one that is rarely expressed with candor in the public scientific discourse: that, as with any other chronic disease, pharmacotherapy should constitute the central pillar in the treatment of obesity, while other approaches retain an important but complementary role
Unwanted weight and constant fatigue often go handinhand
Did you know that its estrogen that causes aggressiveness and not testosterone
Active ongoing research into the roles of ubiquinol and D-ribose in HFpEF may provide clinicians with additional management opportunities. Ribose Experts Weigh in Bioenergy Life Science (BLS), the makers of a ribose energy ingredient, discussed the prospect of this clinical trial
It may also be appealing for those navigating the financial barriers of traditional GLP-1 therapy
These proteins are also very satisfactory for consumers, which adds to their overall value as a food ingredient